Clinical trial
A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and…
NCT00481026 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00481026 |
|---|---|
| Title | A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression |
| Official title | A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression |
| Lead sponsor | Bayside Health, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Major Depression |
| Intervention type | Device |
| Interventions | transcranial direct current stimulation (tDCS), active tDCS |
| Enrollment | 31 |
| Start date | Aug 1, 2007 |
| Primary completion | May 1, 2013 |
| Completion | May 1, 2013 |
| First posted | Jun 1, 2007 |
| Last update posted | Oct 14, 2020 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: